Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00719810 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy Study of a Fluoroquinolone to Treat Complicated Skin Infections
A Phase 2 study of Staphylococcal Skin Infections and Skin Structure Infections, sponsored by Melinta Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
- 14
- Study locations
NCT00719810 is a Phase 2 study of Staphylococcal Skin Infections and Skin Structure Infections that has completed, run by Melinta Therapeutics. The registered enrollment target is 150 participants. The trial reports 14 study locations across 7 states.
The verdict
NCT00719810, a Phase 2 study of Staphylococcal Skin Infections and Skin Structure Infections, has completed, sponsored by Melinta Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
- 14
- Study locations
Study Summary
The purpose of this study is to assess the efficacy, safety and tolerability of RX-3341 (delafloxacin), a fluoroquinolone, versus tigecycline, a glycylcycline antibacterial drug, in the treatment of complicated skin and skin structure infections.
Conditions Studied
Interventions
- DRUG delafloxacin
- DRUG tigecycline
Study Locations (14)
California
- Physician Alliance Research Center - Anaheim
- Quality of Life Medical Center, LLC - Hawaiian Gardens
- Tri City Medical Center - Oceanside
- Crest Clinical Trials - Santa Ana
Georgia
- Joseph M. Still Research Foundation, Inc. - Augusta
- Southeast Regional Research Group - Columbus
- Southeast Regional Research Group - Ludowici
- Southeast Regional Research Group - Savannah
Texas
- West Houston Clinical Research Services - Houston
- Westbury Medical Clinic - Houston
Florida
- Internal Medicine Associates of Lee County - Fort Myers
Montana
- St. James Health Care - Butte
Ohio
- Riverside Methodist Hospital - Columbus
Other
- Clinical Research Puerto Rico, Inc - San Juan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2008-06 |
| Est. Completion | 2008-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00719810
The ClinicalTrials.gov registry entry for NCT00719810 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Melinta Therapeutics, which has 31 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Staphylococcal Skin Infections appearing as the primary indexed condition, and to 2 interventions - of which delafloxacin is the first listed.
NCT00719810 reports 14 study locations spanning 7 distinct geographic areas - top geographies include California, Georgia, Texas.
Frequently Asked Questions
What is clinical trial NCT00719810 about?
NCT00719810 is a clinical study titled "Safety and Efficacy Study of a Fluoroquinolone to Treat Complicated Skin Infections". The purpose of this study is to assess the efficacy, safety and tolerability of RX-3341 (delafloxacin), a fluoroquinolone, versus tigecycline, a glycylcycline antibacterial drug, in the treatment of complicated skin and skin structure infections.
What is the current status of trial NCT00719810?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2008-06. Estimated completion is 2008-10.
What conditions does trial NCT00719810 study?
This clinical trial studies the following conditions: Staphylococcal Skin Infections, Skin Structure Infections, Bacterial Skin Diseases.
What interventions are being tested in trial NCT00719810?
The interventions under investigation include: delafloxacin (DRUG), tigecycline (DRUG).
Who is sponsoring clinical trial NCT00719810?
This trial is sponsored by Melinta Therapeutics, which has 31 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00719810 being conducted?
This trial has 14 study locations across California, Florida, Georgia, Montana, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Staphylococcal Skin Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.